FGF21 and Insulin resistance: Altogether, this study demonstrates that administration of AAV vectors that leads to therapeutically relevant levels of circulating FGF21 is safe in the long‐term in healthy and may be used to counteract the increase in body weight and insulin resistance associated with aging.